Neurodegenerative disease risk is reflective of a complex polygenic architecture and co-occurring variants in genes, such as TREM2, MAPT, GRN, GBA and LRRK2, may modulate or interact with APOE ε4-associated molecular pathways. This evidence concerns the gene MAPT and glycogen storage disease VI.